| Entry |
|
|---|
| Name |
Capravirine (USAN/INN) |
|---|
| Formula |
C20H20Cl2N4O2S
|
|---|
| Exact mass |
450.0684
|
|---|
| Mol weight |
451.3694
|
|---|
| Structure |
|
|---|
| Class |
Antiviral
DG01889 Non-nucleoside reverse transcriptase inhibitor (NNRTI)
DG03107 Anti-HIV agent
DG01656 HIV reverse transcriptase inhibitor
|
|---|
| Efficacy |
Antiviral, Reverse transcriptase inhibitor |
|---|
| Target |
HIV-1 reverse transcriptase [KO: K24802] |
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antiviral
DG01889 Non-nucleoside reverse transcriptase inhibitor (NNRTI)
D03371 Capravirine
DG03107 Anti-HIV agent
DG01656 HIV reverse transcriptase inhibitor
D03371 Capravirine
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
HIV reverse transcriptase inhibitor
D03371 Capravirine (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 29
1 C8y C 22.7249 -16.3578
2 C8y C 24.1290 -16.3578
3 N4y N 24.5629 -15.0224
4 C8y C 23.4270 -14.1970
5 N5x N 22.2911 -15.0224
6 C1b C 23.4270 -12.7773
7 C1b C 25.7663 -14.3218
8 O7a O 22.1990 -12.0683
9 C8y C 25.7640 -12.9075
10 C8x C 26.9535 -12.2177
11 C8x C 26.9509 -10.8145
12 N5x N 25.7344 -10.1152
13 C8x C 24.5448 -10.8049
14 C8x C 24.5474 -12.2081
15 C1c C 22.0249 -17.5702
16 C1a C 22.7249 -18.7826
17 S2a S 24.8290 -17.5702
18 C1a C 20.6500 -17.5702
19 C8y C 26.2500 -17.5702
20 C7a C 20.9923 -12.7649
21 N1a N 19.7750 -12.0622
22 O6a O 20.9924 -14.1400
23 C8x C 26.9499 -18.7825
24 C8y C 28.3499 -18.7825
25 C8x C 29.0499 -17.5701
26 C8y C 28.3500 -16.3578
27 C8x C 26.9500 -16.3578
28 X Cl 29.0405 -15.1621
29 X Cl 29.0403 -19.9780
BOND 31
1 1 2 2
2 2 3 1
3 3 4 1
4 4 5 2
5 1 5 1
6 4 6 1
7 3 7 1
8 6 8 1
9 7 9 1
10 9 10 2
11 10 11 1
12 11 12 2
13 12 13 1
14 13 14 2
15 9 14 1
16 1 15 1
17 15 16 1
18 2 17 1
19 15 18 1
20 17 19 1
21 8 20 1
22 20 21 1
23 20 22 2
24 19 23 2
25 23 24 1
26 24 25 2
27 25 26 1
28 26 27 2
29 19 27 1
30 26 28 1
31 24 29 1
|
|---|
